Developer docs
API playgroundTry for free, no card

Search company profiles

mediproCan® Pharma GmbH

Full company profile

uuid004vg47

Namestring
mediproCan® Pharma GmbH
Legal namestring
mediproCan Pharma GmbH
Websiteurl
mediprocan.com
Company typeenum
Private
Founded yearint
1984
Descriptiontext

mediproCan® Pharma GmbH is a privately held German pharmaceutical manufacturer, importer, and wholesaler of medical cannabis, headquartered in Neumünster (Memellandstr. 2, 24537) and operating under the supervisory authority of the Landesamt für soziale Dienste des Landes Schleswig-Holstein. The company holds GMP (Good Manufacturing Practice) and GDP (Good Distribution Practice) certifications and produces cannabis flowers and extracts under strict pharmaceutical quality guidelines ensuring consistent composition and concentration of active ingredients. Leadership comprises Managing Directors Felix Kühl and Dr. Martin Haase, with Anna Kühl as CMO. The company claims 40 years of pharmaceutical industry experience, dating its heritage to 1984, though its cannabis-focused commercial activity began only in April 2023 with the launch of the "Juwel" premium flower line, followed in October 2024 by the "Gloweed" craft sub-brand debuting the MYKONOZ strain.

The company operates a sales-led, B2B go-to-market model. Revenue mechanics flow through three distribution layers: pharmaceutical wholesalers, licensed pharmacies dispensing against prescriptions, and a DocCheck-authenticated webshop for healthcare professional ordering — all serving the German medical cannabis market under §31 Paragraph 6 SGB V. Pricing is not publicly disclosed, and products are prescription-only and subject to German narcotics law. The company has no disclosed external investors, no parent company, and no disclosed funding rounds despite operating an "Investoren" page that signals future capital intent.

The underlying technology is conventional pharmaceutical manufacturing adapted to a regulated botanical input — no proprietary software platform, AI/ML systems, or data flywheel mechanics are evidenced. Marketing and customer engagement are conducted through the corporate website, LinkedIn and Instagram presence, and participation in industry fairs and events. With only 5 disclosed employees, the operation is small relative to its GMP-certified manufacturing footprint, suggesting a high-leverage model dependent on a narrow set of channel partners.

Short descriptiontext

mediproCan® Pharma GmbH is a German GMP and GDP certified manufacturer, importer, and wholesaler of medical cannabis flowers and extracts, headquartered in Neumünster. It sells through pharmaceutical wholesalers, licensed pharmacies, and a DocCheck-secured B2B webshop serving the German prescription market, with the Juwel and Gloweed product lines.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNeumünster, Germany
HQ citystring
Neumünster
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical cannabis manufacturing, pharmaceutical cannabis wholesale, GMP certified cannabis, prescription cannabis flowers, cannabis extracts production
Industry2 codes
PRIMARYCRANAFAI
Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAFAG
Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code3 codes
  • Medicinal Chemicals & Botanical Products2833
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Medical Cannabis Pharmaceuticals
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Cannabis Products
TypeOne Time License
Description

Manufacturing and distribution of medical cannabis flowers and extracts to wholesalers, pharmacies, and healthcare providers in the German market. Products include premium cannabis strains with different THC contents.

mediprocan.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Gloweed
Description

Premium sub-brand featuring high-quality craft cannabis strains. Launched as part of mediproCan's entry into the craft cannabis market segment.

mediprocan.com
Core offering1 text field

mediproCan® Pharma GmbH is a German GMP and GDP certified manufacturer, importer, and wholesaler of medical cannabis. The company produces and distributes pharmaceutical-grade cannabis flowers and extracts, including its premium Juwel product line and the Gloweed craft sub-brand, selling to wholesalers, licensed pharmacies, and healthcare professionals in Germany. The company controls the full supply chain from development through production to logistics, ensuring consistent composition and concentration of active ingredients.

Differentiator
Functional benefit
Problem solved
Product and service4 records
1Juwel Premium Cannabis Flower Line
CategoryMedical cannabis flowers
Description

Premium product line of medical cannabis flowers offered in multiple strains with varying THC contents, launched in April 2023 as the company's market entry. Sold through wholesalers, pharmacies, and healthcare professionals in Germany for prescription dispensing to patients with qualifying conditions under §31 Paragraph 6 SGB V.

2Gloweed Premium Craft Sub-Brand
CategoryMedical cannabis flowers
Description

Premium sub-brand of mediproCan® featuring high-quality craft cannabis strains with unique terpene profiles, targeting patients who appreciate refined cannabis experiences. Sold to wholesalers, pharmacies, and healthcare professionals in Germany under prescription channels.

3MYKONOZ Craft Cannabis Strain
CategoryMedical cannabis flowers
Description

First craft cannabis strain under the Gloweed sub-brand, containing 23% THC, with a rich terpene profile, grown indoors in Canada using 'living soil' cultivation methods, available in limited small batches for the German medical cannabis market.

4Medical Cannabis Flowers and Extracts Portfolio
CategoryMedical cannabis pharmaceuticals
Description

German GMP and GDP certified product portfolio of medical cannabis flowers and extracts, manufactured and distributed to wholesalers, pharmacies, and healthcare providers for patients with serious medical conditions including chronic pain, sleep disorders, psychiatric disorders (AD(H)S, anxiety, depression, PTSD), neurological diseases (migraine, multiple sclerosis, epilepsy), gastrointestinal diseases, skin diseases, cancer symptoms, and menstrual/endocrine conditions.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Four20 Pharma is a German pharmaceutical company specializing in medical cannabis products, distributing cannabis flowers and extracts to German pharmacies. Comparable as a German-focused GMP-certified medical cannabis supplier.

TypeDirect peer
Description

Demecan is a German GMP-certified producer and distributor of medical cannabis, headquartered in Berlin. It is the closest direct competitor to mediproCan in the German medical cannabis wholesale and pharmacy channel.

TypeBroad incumbent
Description

Aphria (now under Tilray) is a Canadian cannabis producer with European supply operations. Comparable as a GMP-certified medical cannabis wholesaler serving the German market, though it operates at significantly larger scale.

TypeBroad incumbent
Description

Canopy Growth operates a broad medical cannabis portfolio with German-market presence through its Stada-branded distribution. Comparable as a large-scale GMP-certified medical cannabis supplier competing in the same pharmacy channel as mediproCan.

TypeDirect peer
Description

Bedrocan is a Dutch GMP-certified medical cannabis producer that has historically been a major supplier to the German market. Comparable to mediproCan as a pharma-grade cannabis manufacturer/wholesaler serving German pharmacies.

TypeDirect peer
Description

Cannamedical is a German pharmaceutical company importing and distributing medical cannabis flowers and extracts to German pharmacies. Comparable to mediproCan in both the GMP-certified wholesale model and the pharmacy-channel go-to-market.

TypeBroad incumbent
Description

Aurora Cannabis is a Canadian licensed producer with European operations including Germany. Comparable as a GMP-certified medical cannabis wholesaler in Germany, but materially larger and more diversified.

TypeBroad incumbent
Description

STADA is a major German generics and specialty pharma company active in medical cannabis distribution through partnerships. Comparable to mediproCan as a German-headquartered pharma partner with medical cannabis offerings, though far larger and broader.

TypeDirect peer
Description

Sanity Group is a Berlin-based medical cannabis company operating across cultivation, manufacturing, and distribution in Germany. It directly overlaps with mediproCan in the German pharmacy-supply channel.

10Tilray Medical
TypeBroad incumbent
Description

Tilray is a globally scaled Canadian medical cannabis producer with significant German distribution. It competes with mediproCan in the German pharmacy channel but is a much broader incumbent with global operations.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

mediproCan® Pharma GmbH

Medical Cannabis Pharmaceuticalsmediprocan.com

mediproCan® Pharma GmbH is a German GMP and GDP certified manufacturer, importer, and wholesaler of medical cannabis flowers and extracts, headquartered in Neumünster. It sells through pharmaceutical wholesalers, licensed pharmacies, and a DocCheck-secured B2B webshop serving the German prescription market, with the Juwel and Gloweed product lines.

What mediproCan® Pharma GmbH does

mediproCan® Pharma GmbH is a privately held German pharmaceutical manufacturer, importer, and wholesaler of medical cannabis, headquartered in Neumünster (Memellandstr. 2, 24537) and operating under the supervisory authority of the Landesamt für soziale Dienste des Landes Schleswig-Holstein. The company holds GMP (Good Manufacturing Practice) and GDP (Good Distribution Practice) certifications and produces cannabis flowers and extracts under strict pharmaceutical quality guidelines ensuring consistent composition and concentration of active ingredients. Leadership comprises Managing Directors Felix Kühl and Dr. Martin Haase, with Anna Kühl as CMO. The company claims 40 years of pharmaceutical industry experience, dating its heritage to 1984, though its cannabis-focused commercial activity began only in April 2023 with the launch of the "Juwel" premium flower line, followed in October 2024 by the "Gloweed" craft sub-brand debuting the MYKONOZ strain.

The company operates a sales-led, B2B go-to-market model. Revenue mechanics flow through three distribution layers: pharmaceutical wholesalers, licensed pharmacies dispensing against prescriptions, and a DocCheck-authenticated webshop for healthcare professional ordering — all serving the German medical cannabis market under §31 Paragraph 6 SGB V. Pricing is not publicly disclosed, and products are prescription-only and subject to German narcotics law. The company has no disclosed external investors, no parent company, and no disclosed funding rounds despite operating an "Investoren" page that signals future capital intent.

The underlying technology is conventional pharmaceutical manufacturing adapted to a regulated botanical input — no proprietary software platform, AI/ML systems, or data flywheel mechanics are evidenced. Marketing and customer engagement are conducted through the corporate website, LinkedIn and Instagram presence, and participation in industry fairs and events. With only 5 disclosed employees, the operation is small relative to its GMP-certified manufacturing footprint, suggesting a high-leverage model dependent on a narrow set of channel partners.

mediproCan® Pharma GmbH firmographics

Firmographics
Name
mediproCan® Pharma GmbH
Legal name
mediproCan Pharma GmbH
Website
https://mediprocan.com
Company type
Private
Founded year
1984
Operating status
Operating
Headcount range
1–10 employees
Short description
mediproCan® Pharma GmbH is a German GMP and GDP certified manufacturer, importer, and wholesaler of medical cannabis flowers and extracts, headquartered in Neumünster. It sells through pharmaceutical wholesalers, licensed pharmacies, and a DocCheck-secured B2B webshop serving the German prescription market, with the Juwel and Gloweed product lines.
Ownership category
akta.pro rank

mediproCan® Pharma GmbH industry classification

Industry
Product category
Medical Cannabis Pharmaceuticals
NAICS
Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYCRANAFAI
Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAFAG
Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)

Keywords

  • Medical cannabis manufacturing
  • Pharmaceutical cannabis wholesale
  • GMP certified cannabis
  • Prescription cannabis flowers
  • Cannabis extracts production

Where mediproCan® Pharma GmbH is headquartered

Location

Headquarters

HQ city
Neumünster
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

mediproCan® Pharma GmbH business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Medical Cannabis Products: Manufacturing and distribution of medical cannabis flowers and extracts to wholesalers, pharmacies, and healthcare providers in the German market. Products include premium cannabis strains with different THC contents.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

mediproCan® Pharma GmbH product offering

Product offering

Core offering

mediproCan® Pharma GmbH is a German GMP and GDP certified manufacturer, importer, and wholesaler of medical cannabis. The company produces and distributes pharmaceutical-grade cannabis flowers and extracts, including its premium Juwel product line and the Gloweed craft sub-brand, selling to wholesalers, licensed pharmacies, and healthcare professionals in Germany. The company controls the full supply chain from development through production to logistics, ensuring consistent composition and concentration of active ingredients.

Differentiator

Problem solved

Functional benefit

Brands

  • Gloweed: Premium sub-brand featuring high-quality craft cannabis strains. Launched as part of mediproCan's entry into the craft cannabis market segment.

Products and services

  • Juwel Premium Cannabis Flower Line Premium product line of medical cannabis flowers offered in multiple strains with varying THC contents, launched in April 2023 as the company's market entry. Sold through wholesalers, pharmacies, and healthcare professionals in Germany for prescription dispensing to patients with qualifying conditions under §31 Paragraph 6 SGB V.
  • Gloweed Premium Craft Sub-Brand Premium sub-brand of mediproCan® featuring high-quality craft cannabis strains with unique terpene profiles, targeting patients who appreciate refined cannabis experiences. Sold to wholesalers, pharmacies, and healthcare professionals in Germany under prescription channels.
  • MYKONOZ Craft Cannabis Strain First craft cannabis strain under the Gloweed sub-brand, containing 23% THC, with a rich terpene profile, grown indoors in Canada using 'living soil' cultivation methods, available in limited small batches for the German medical cannabis market.
  • Medical Cannabis Flowers and Extracts Portfolio German GMP and GDP certified product portfolio of medical cannabis flowers and extracts, manufactured and distributed to wholesalers, pharmacies, and healthcare providers for patients with serious medical conditions including chronic pain, sleep disorders, psychiatric disorders (AD(H)S, anxiety, depression, PTSD), neurological diseases (migraine, multiple sclerosis, epilepsy), gastrointestinal diseases, skin diseases, cancer symptoms, and menstrual/endocrine conditions.

Companies that use mediproCan® Pharma GmbH

Customer profile

Segments3 records

Ideal customer profiles3 records

mediproCan® Pharma GmbH technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

mediproCan® Pharma GmbH partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

mediproCan® Pharma GmbH competitors and assessment

Company assessment

Regional players

  • Four20 Pharma: Four20 Pharma is a German pharmaceutical company specializing in medical cannabis products, distributing cannabis flowers and extracts to German pharmacies. Comparable as a German-focused GMP-certified medical cannabis supplier.

Direct peers

  • Demecan: Demecan is a German GMP-certified producer and distributor of medical cannabis, headquartered in Berlin. It is the closest direct competitor to mediproCan in the German medical cannabis wholesale and pharmacy channel.
  • Bedrocan: Bedrocan is a Dutch GMP-certified medical cannabis producer that has historically been a major supplier to the German market. Comparable to mediproCan as a pharma-grade cannabis manufacturer/wholesaler serving German pharmacies.
  • Cannamedical Pharma: Cannamedical is a German pharmaceutical company importing and distributing medical cannabis flowers and extracts to German pharmacies. Comparable to mediproCan in both the GMP-certified wholesale model and the pharmacy-channel go-to-market.
  • Sanity Group: Sanity Group is a Berlin-based medical cannabis company operating across cultivation, manufacturing, and distribution in Germany. It directly overlaps with mediproCan in the German pharmacy-supply channel.

Broad incumbents

  • Aphria (now part of Tilray): Aphria (now under Tilray) is a Canadian cannabis producer with European supply operations. Comparable as a GMP-certified medical cannabis wholesaler serving the German market, though it operates at significantly larger scale.
  • Canopy Growth Corporation: Canopy Growth operates a broad medical cannabis portfolio with German-market presence through its Stada-branded distribution. Comparable as a large-scale GMP-certified medical cannabis supplier competing in the same pharmacy channel as mediproCan.
  • Aurora Cannabis: Aurora Cannabis is a Canadian licensed producer with European operations including Germany. Comparable as a GMP-certified medical cannabis wholesaler in Germany, but materially larger and more diversified.
  • STADA Arzneimittel AG: STADA is a major German generics and specialty pharma company active in medical cannabis distribution through partnerships. Comparable to mediproCan as a German-headquartered pharma partner with medical cannabis offerings, though far larger and broader.
  • Tilray Medical: Tilray is a globally scaled Canadian medical cannabis producer with significant German distribution. It competes with mediproCan in the German pharmacy channel but is a much broader incumbent with global operations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

mediproCan® Pharma GmbH social profiles

Digital presence

mediproCan® Pharma GmbH financial estimates

Financial estimate

Revenue estimate

Valuation estimate

mediproCan® Pharma GmbH leadership team

Management profile

Number of profiles

Profiles3 records

mediproCan® Pharma GmbH funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

mediproCan® Pharma GmbH M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about mediproCan® Pharma GmbH

What does mediproCan® Pharma GmbH do?

mediproCan® Pharma GmbH is a German GMP and GDP certified manufacturer, importer, and wholesaler of medical cannabis. The company produces and distributes pharmaceutical-grade cannabis flowers and extracts, including its premium Juwel product line and the Gloweed craft sub-brand, selling to wholesalers, licensed pharmacies, and healthcare professionals in Germany. The company controls the full supply chain from development through production to logistics, ensuring consistent composition and concentration of active ingredients.

Is mediproCan® Pharma GmbH a public or private company?

mediproCan® Pharma GmbH is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was mediproCan® Pharma GmbH founded?

mediproCan® Pharma GmbH was founded in 1984. It employs 1 to 10 people.

Where is mediproCan® Pharma GmbH based?

mediproCan® Pharma GmbH is headquartered in Neumünster, Germany, in the Europe region.

How does mediproCan® Pharma GmbH make money?

One revenue line is on record: medical Cannabis Products.

Who are mediproCan® Pharma GmbH's main competitors?

Four20 Pharma is listed as a regional player. Direct peers are Demecan, Bedrocan, Cannamedical Pharma and Sanity Group. Broad incumbents are Aphria (now part of Tilray), Canopy Growth Corporation, Aurora Cannabis, STADA Arzneimittel AG and Tilray Medical.

Does mediproCan® Pharma GmbH have an API?

No public API is recorded for mediproCan® Pharma GmbH.

What industry is mediproCan® Pharma GmbH in?

mediproCan® Pharma GmbH's product category is Medical Cannabis Pharmaceuticals. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services), with a secondary code of CRANAFAG, Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales